Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 4/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | MET | P08581 | 3/20 | 1.00 |
| ▸ | KIT | P10721 | 3/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 3/20 | 1.00 |
| ▸ | SRC | P12931 | 3/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 1.00 |
| ▸ | G6PD | P11413 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | NSD2 | O96028 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hematoxylin SCHEMBL30089789 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL29366910 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL1784957 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL29360033 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL30101752 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL7026124 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL29357236 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL19654 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL1747 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL19816198 | 0.99 | MAPT (0.97) | MAPTKDM4EHPGDMAPK1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11642437-B2 | Autologous bone graft substitute composition comprising bioceramic particles of different geometry | GENERA ISTRAZIVANJA D.O.O. | 2023-05-09 | — | — | US | disclosed |
| CN-112574163-B | Method for synthesizing Brazilin natural product (+) -Brazilin | 山西省肿瘤研究所 | 2023-04-07 | — | — | CN | disclosed |
| CN-115552214-A | Semi-synthesis and use of racemic hematoxylin | 文塔纳医疗系统公司 | 2022-12-30 | — | — | CN | disclosed |
| US-20220023494-A1 | Autologous Bone Graft Substitute Composition Comprising Bioceramic Particles of Different Geometry | GENERA ISTRAZIVANJA D.O.O. (HR) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | MAPT 2113/4885KDM4E 984/4885HPGD 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.